Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease

Abstract

Patients with Cushing's disease have osteoporosis which needs to be rapidly reversed to limit the risk of fracture. The results of the present study show that a 12 month treatment period with alendronate induced an improvement in bone mineral density greater than in untreated patients.